Quarterly report pursuant to Section 13 or 15(d)

Accrued expenses and other current liabilities

v3.24.3
Accrued expenses and other current liabilities
9 Months Ended
Sep. 30, 2024
Accrued expenses and other current liabilities  
Accrued expenses and other current liabilities

Note 10 — Accrued expenses and other current liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):

​

​

​

​

​

​

​

​

​

September 30, 

​

December 31, 

​

    

2024

    

2023

Accrued clinical and development expenditure

​

$

13,281

​

$

12,351

Accrued employee expenses

​

​

11,276

​

​

13,226

VAT payable

​

​

—

​

​

1,398

Other accrued expenditure

​

​

5,780

​

​

3,277

Other

​

 

1,167

​

 

51

​

​

$

31,504

​

$

30,303

​